Jonathan Messika

8.1k total citations · 2 hit papers
95 papers, 2.6k citations indexed

About

Jonathan Messika is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Epidemiology. According to data from OpenAlex, Jonathan Messika has authored 95 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Pulmonary and Respiratory Medicine, 31 papers in Surgery and 28 papers in Epidemiology. Recurrent topics in Jonathan Messika's work include Transplantation: Methods and Outcomes (25 papers), Nosocomial Infections in ICU (17 papers) and Respiratory Support and Mechanisms (13 papers). Jonathan Messika is often cited by papers focused on Transplantation: Methods and Outcomes (25 papers), Nosocomial Infections in ICU (17 papers) and Respiratory Support and Mechanisms (13 papers). Jonathan Messika collaborates with scholars based in France, United States and Réunion. Jonathan Messika's co-authors include Jean-Damien Ricard, Benjamin Sztrymf, Didier Dreyfuss, Joan Ramón Masclans, Berta Caralt, Oriol Roca, Marina García-de-Acilu, Stéphane Gaudry, Fabrice Bertrand and Leon Rusel and has published in prestigious journals such as JAMA, Neurology and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Jonathan Messika

87 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

An Index Combining Respiratory Rate and Oxygenation to Predict Outcome of Nasal High-Flow Therapy

2018 406 citations Oriol Roca, Berta Caralt et al. American Journal of Respiratory and Critical Care Medicine profile →
Predicting success of high-flow nasal cannula in pneumonia patients with hypoxemic respiratory failure: The utility of the ROX index

2016 278 citations Oriol Roca, Jonathan Messika et al. Journal of Critical Care profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jonathan Messika France	20	1.7k	864	704	460	455	95	2.6k
Didier Gruson France	28	1.4k 0.8×	317 0.4×	901 1.3×	923 2.0×	447 1.0×	105	3.0k
Stéphane Gaudry France	22	693 0.4×	271 0.3×	436 0.6×	404 0.9×	266 0.6×	84	1.7k
Nobuaki Shime Japan	29	975 0.6×	293 0.3×	625 0.9×	778 1.7×	275 0.6×	233	2.9k
Gianluigi Li Bassi Spain	29	1.2k 0.7×	270 0.3×	1.6k 2.3×	1.1k 2.5×	333 0.7×	127	3.4k
Alain Durocher France	31	1.3k 0.7×	361 0.4×	1.6k 2.2×	1.1k 2.4×	285 0.6×	83	3.5k
Jean-Damien Ricard France	41	3.7k 2.2×	1.4k 1.6×	1.6k 2.3×	1.1k 2.3×	1.0k 2.3×	148	5.7k
Fekri Abroug Tunisia	37	1.8k 1.1×	320 0.4×	991 1.4×	732 1.6×	838 1.8×	104	4.0k
Hervé Mentec France	20	1.2k 0.7×	161 0.2×	937 1.3×	738 1.6×	464 1.0×	40	2.8k
Andreas Karabinis Greece	25	745 0.4×	271 0.3×	772 1.1×	432 0.9×	221 0.5×	95	2.8k
Saad Nseir France	40	1.8k 1.1×	567 0.7×	2.1k 2.9×	1.6k 3.4×	331 0.7×	161	4.5k

Countries citing papers authored by Jonathan Messika

Since Specialization

Citations

This map shows the geographic impact of Jonathan Messika's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Messika with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Messika more than expected).

Fields of papers citing papers by Jonathan Messika

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan Messika. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Messika. The network helps show where Jonathan Messika may publish in the future.

Co-authorship network of co-authors of Jonathan Messika

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan Messika. A scholar is included among the top collaborators of Jonathan Messika based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan Messika. Jonathan Messika is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gouy‐Pailler, Cédric, Jérôme Devaquet, Jonathan Messika, et al.. (2025). Machine Learning for Predicting Pulmonary Graft Dysfunction After Double-Lung Transplantation: A Single-Center Study Using Donor, Recipient, and Intraoperative Variables. Transplant International. 38. 14965–14965.

Geoffroy, Pierre A., Philippe Pirard, Emmanuelle Corruble, et al.. (2024). Lower risk of hospitalisation for depression following hospitalisation for COVID-19 versus for another reason. Journal of Affective Disorders. 350. 332–339. 3 indexed citations

Etienne, Harry, Jimmy Mullaert, Pierre Cerceau, et al.. (2024). How safe is lung transplantation in patients of 65 years or older? A single-center retrospective cohort. Respiratory Medicine and Research. 86. 101139–101139.

Atchade, Enora, Alexy Tran‐Dinh, Sylvain Jean‐Baptiste, et al.. (2023). Prolonged mechanical ventilation after lung transplantation: risks factors and consequences on recipient outcome. Frontiers in Medicine. 10. 1160621–1160621. 10 indexed citations

Picard, C., Martine Reynaud‐Gaubert, Ana Nieves, et al.. (2023). Effect of antifibrotic agents on postoperative complications after lung transplantation for idiopathic pulmonary fibrosis. Respirology. 29(1). 71–79. 2 indexed citations

Grall, Nathalie, Vincent Bunel, C. Godet, et al.. (2023). Risk of Bronchial Complications After Lung Transplantation With Respiratory Corynebacteria. Results From a Monocenter Retrospective Cohort Study. Transplant International. 36. 10942–10942. 1 indexed citations

Tanaka, Sébastien, Christian de Tymowski, Alexy Tran‐Dinh, et al.. (2023). Low HDL-Cholesterol Concentrations in Lung Transplant Candidates are Strongly Associated With One-Year Mortality After Lung Transplantation. Transplant International. 36. 10841–10841. 1 indexed citations

Roux, Antoine, Vincent Bunel, Jonathan Messika, et al.. (2023). First use of imlifidase desensitization in a highly sensitized lung transplant candidate: a case report. American Journal of Transplantation. 23(2). 294–297. 7 indexed citations

Pirard, Philippe, Baptiste Pignon, Vittorio Perduca, et al.. (2022). Hospitalization for COVID-19 is associated with a higher risk of subsequent hospitalization for psychiatric disorders: A French nationwide longitudinal study comparing hospitalizations for COVID-19 and for other reasons. European Psychiatry. 65(1). e70–e70. 9 indexed citations

10.

Grimaldi, David, Stéphane Legriel, Nicolas Pichon, et al.. (2022). Ischemic injury of the upper gastrointestinal tract after out-of-hospital cardiac arrest: a prospective, multicenter study. Critical Care. 26(1). 59–59. 9 indexed citations

11.

Dauriat, Gaëlle, L. Beaumont, Liêm Binh Luong Nguyen, et al.. (2022). Efficacy of three COVID-19 vaccine doses in lung transplant recipients: a multicentre cohort study. European Respiratory Journal. 61(1). 2200502–2200502. 16 indexed citations

12.

Duboc, Henri, Heithem Soliman, Benjamin Sztrymf, et al.. (2021). Are bedside colonoscopies performed in intensive care unit really useful?. Journal of Critical Care. 63. 56–61. 1 indexed citations

13.

Lê, Minh, Quentin Le Hingrat, Pierre Jaquet, et al.. (2020). Removal of Remdesivir’s Metabolite GS-441524 by Hemodialysis in a Double Lung Transplant Recipient with COVID-19. Antimicrobial Agents and Chemotherapy. 64(11). 16 indexed citations

14.

Dangers, Laurence, Jonathan Giovannelli, G. Mangiapan, et al.. (2020). Antiplatelet Drugs and Risk of Bleeding After Bedside Pleural Procedures. CHEST Journal. 159(4). 1621–1629. 9 indexed citations

15.

Ricard, Jean-Damien, Fadia Dib, Marina Esposito‐Farèse, Jonathan Messika, & Christophe Girault. (2018). Comparison of high flow nasal cannula oxygen and conventional oxygen therapy on ventilatory support duration during acute-on-chronic respiratory failure: study protocol of a multicentre, randomised, controlled trial. The ‘HIGH-FLOW ACRF’ study. BMJ Open. 8(9). e022983–e022983. 20 indexed citations

16.

Roca, Oriol, Berta Caralt, Jonathan Messika, et al.. (2018). An Index Combining Respiratory Rate and Oxygenation to Predict Outcome of Nasal High-Flow Therapy. American Journal of Respiratory and Critical Care Medicine. 199(11). 1368–1376. 406 indexed citations breakdown →

17.

Jean‐Baptiste, Sylvain, Jonathan Messika, David Hajage, et al.. (2018). Clinical impact of upper gastrointestinal endoscopy in critically ill patients with suspected bleeding. Annals of Intensive Care. 8(1). 75–75. 5 indexed citations

18.

Messika, Jonathan, Stéphane Gaudry, Florence Tubach, et al.. (2017). Underreporting of End-of-Life Decisions in Critical Care Trials: A Call to Modify the Consolidated Standards of Reporting Trials Statement. American Journal of Respiratory and Critical Care Medicine. 197(2). 263–266. 7 indexed citations

19.

Messika, Jonathan, Benjamin Sztrymf, Fabrice Bertrand, et al.. (2014). Risks of nonsteroidal antiinflammatory drugs in undiagnosed intensive care unit pneumococcal pneumonia: Younger and more severely affected patients. Journal of Critical Care. 29(5). 733–738. 33 indexed citations

20.

Messika, Jonathan, Stéphane Gaudry, Romain Miguel-Montanes, et al.. (2014). Use of High-Flow Nasal Cannula Oxygen Therapy in Subjects With ARDS: A 1-Year Observational Study. Respiratory Care. 60(2). 162–169. 132 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact